Author of the publication

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

The Parkinson related LRRK2 mutation R1441C/G/H impairs PKA phosphorylation of LRRK2 and disrupts its interaction with 14-3-3, , , , , , , , , and . PNAS, 111 (1): E34-43 (2014)Cyclic nucleotide analogs as pharmacological tools for studying signaling pathways, , , , and . Cyclic Nucleotide Signaling, CRC Press, (2015)AKAP18:PKA-RIIα structure reveals crucial anchor points for recognition of regulatory subunits of PKA, , , , , , , , , and 4 other author(s). Biochemical Journal, 473 (13): 1881-1894 (2016)Utilisation of antibody microarrays for the selection of specific and informative antibodies from recombinant library binders of unknown quality, , , , , , , , , and 6 other author(s). New Biotechnology, 33 (5, Part A): 574-581 (2016)The role of a parasite-specific D-site in activation of Plasmodium falciparum cGMP-dependent protein kinase, , , , , and . BMC Pharmacology and Toxicology, 16 (Suppl 1): A51 (2015)Defining A-Kinase Anchoring Protein (AKAP) Specificity for Protein Kinase A Subunit RI (PKA-RI), , , , and . ChemBioChem, 17 (8): 693-697 (2016)ENRICHMENT OF AMYLOID-beta-PEPTIDES FROM CEREBROSPINAL FLUID USING SINGLE SOLID PHASE EXTRACTION BEADS AND SUBSEQUENT MASS SPECTROMETRY ANALYSIS, , , , , , and . CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 1, page S772. ()Investigating PKA-RII specificity using analogs of the PKA:AKAP peptide inhibitor STAD-2, , , , , , and . Bioorganic & Medicinal Chemistry, 26 (6): 1174 - 1178 (2018)Constrained Peptides and Biological Targets.Cyclic nucleotides as affinity tools: phosphorothioate cAMP analogues address specific PKA subproteomes, , , , , and . N Biotechnol, 28 (4): 294-301 (July 2011)Tetramerization dynamics of the C-terminal domain underlies isoform-specific cAMP-gating in Hyperpolarization-activated Cyclic Nucleotide gated channels, , , , , , , , , and 3 other author(s). J Biol Chem, 286 (52): 44811-20 (2011)